TIMD4 and non-small cell lung carcinoma: In summary, our findings potentially shed light on the mechanism of N-glycosylated TIM-4 and provide a valuable biomarker for developing drugs targeting N-glycosylation at Asn291 on TIM-4, which may offer a potential new strategy for treating NSCLC in clinical.